1-4 of 4
Kunihiko Fukuchi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Luna Osakabe, DDS, Bungo Saito, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Akemi Utsumi, DDS, Kunihiko Fukuchi, MD, Tsuyoshi Nakamaki, MD, Shouji Hironaka, DDS
Journal: Blood
Blood (2016) 128 (22): 5752.
https://doi.org/10.1182/blood.V128.22.5752.5752
Published: 2016
Journal Articles

Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, MD, Hidetoshi Nakashima, MD, Hirotsugu Ariizumi, MD, Takashi Maeda, MD, Bungo Saito, MD, Kouji Yanagisawa, MD, Shigeru Tomoyasu, MD, Eisuke Shiozawa, MD, Toshiko Yamochi-Onizuka, MD, Hidekazu Ota, MD
Journal: Blood
Blood (2011) 118 (21): 2421.
https://doi.org/10.1182/blood.V118.21.2421.2421
Published: 2011
Journal Articles

Activated c-Jun N-Terminal Kinase Is a Therapeutic Target in Advanced Stage ALK-Negative Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, MD, Toshiko Yamochi-Onizuka, MD, Hidekazu Ota, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2007) 110 (11): 1391.
https://doi.org/10.1182/blood.V110.11.1391.1391
Published: 2007
Journal Articles

Altered Expressions of CD30, c-Jun N-Terminal Kinase, NF-κB and JunB Are Involved in Disease Progression in CD30-Positive Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Takashi Maeda, MD, Kunihiko Fukuchi, MD, Shigeru Tomoyasu, MD
Journal: Blood
Blood (2005) 106 (11): 2827.
https://doi.org/10.1182/blood.V106.11.2827.2827
Published: 2005